Genomic Medicine Sweden (GMS) is a national infrastructure in precision medicine with a vision to implement precision medicine into clinical settings and strengthen the collaboration between Swedish healthcare, research and life-science industry. GMS is comprised of seven regions with university hospitals and universities with a medical faculty. Together with patient organizations, healthcare providers, universities and industry, GMS aims to translate genomic innovation, based on advanced next-generation sequencing technologies, enabling greater precision in the diagnosis, treatment and management of patients with rare diseases, cancer and infectious diseases.

Read more about the experience of implementing precisions medicine in Sweden and what is next for precision medicine in rare diseases:
Building a precision medicine infrastructure at a national level: The Swedish experience,
https://www.cambridge.org/core/journals/cambridge-prisms-precision-medicine/article/building-a-precision-medicine-infrastructure-at-a-national-level-the-swedish-experience/CABCE2479D6FC03577533A388A6841B1
Precision medicine in rare diseases: What is next?, https://onlinelibrary.wiley.com/doi/10.1111/joim.13655